Antibe Therapeutics Inc. (TSE:ATE – Get Free Report) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.30 and traded as low as C$0.26. Antibe Therapeutics shares last traded at C$0.30, with a volume of 167,042 shares.
Antibe Therapeutics Price Performance
The business has a fifty day moving average of C$0.30 and a two-hundred day moving average of C$0.57. The firm has a market capitalization of C$15.64 million, a price-to-earnings ratio of -0.84 and a beta of 0.19. The company has a debt-to-equity ratio of 0.29, a quick ratio of 9.58 and a current ratio of 10.06.
Antibe Therapeutics Company Profile
Antibe Therapeutics Inc, a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs).
Featured Articles
- Five stocks we like better than Antibe Therapeutics
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- The Average 401k Balance by Age Explained
- Consumer Discretionary Stocks Explained
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Antibe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antibe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
